Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
In this video, Sagar Lonial, MD, Winship Cancer Institute of Emory University, Atlanta, GA, comments on the role of non-antibody-based approaches in the treatment of multiple myeloma, highlighting the growing importance of IMiDs and CELMoDs.This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.